News & Trends - MedTech & Diagnostics
J&J MedTech MD charts the path to sustainable, value-based healthcare: Reimagining Healthcare Senior Leadership Series
MedTech & Diagnostics News: In a thought-provoking vodcast for the Reimagining Healthcare senior leadership series, Sue Martin, Managing Director of J&J MedTech and Chair of the MTAA Board, delved into how value-based healthcare could deliver a sustainable health system in the next 10-15 years in Australia.
“It’s about how a patient’s going to be at the centre of our decision making. How do we make health an investment as opposed to a cost, outcomes versus output, value versus price? This is a future that medtech can play such an active role in,” she stated.
With estimates from the Australian Healthcare & Hospitals Association (AHHA) suggesting that up to 30% of healthcare is considered low-value due to ineffectiveness or high costs with marginal benefits, Martin highlighted real-world examples in analysing this trend.
Addressing the fragmentation among stakeholders such as private insurers, private hospitals, and public hospitals, Martin discussed the opportunity for industry to challenge the boundaries and shape the conversation. She also identified Australian policy initiatives that align with the value-based healthcare agenda.
“Every state and territory has consistently identified paying for value and outcomes as a priority reform through the National Health Reform agreement. It would be fair to say that little progress has been made on this shared objective.” However, with negotiations underway for the new National Health Reform Agreement (NHRA), Martin feels “optimistic about the policy opportunities that we have ahead of us, but it is going to take reform to embed this within our system.”
Looking to international examples of value-based healthcare, Martin shared her perspective on how other countries’ successes and failures can inform Australia’s approach.
Concluding the interview, she outlined the essential short-term actions needed to lay the groundwork for long-term transformation and achieve the envisioned future of value-based healthcare.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - MedTech & Diagnostics
APAC medtech company scores TGA approval in heart disease
MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]
MoreNews & Trends - MedTech & Diagnostics
New state-based pilot to back home-grown medtech innovation
MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]
MoreNews & Trends - Pharmaceuticals
Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis
Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]
MoreNews & Trends - Pharmaceuticals
Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives
Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]
More